NASDAQ · Analyst Forecast

TherapeuticsMD, Inc. (TXMD) Stock Forecast & Price Target

$1.91 NASDAQ: TXMD Market Cap $22.11M

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 16, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering TherapeuticsMD, Inc. (TXMD), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For TherapeuticsMD, Inc., analysts forecast revenue falling from $70.00M in 2022 to $9.50M in 2027; the average estimate for 2027 earnings per share is $0.19; 1 analyst contribute to these figures. These are forecasts published by analysts, not results.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2022$69.89M$70.00M$70.11M1
2023$1.58M$2.00M$2.42M1
2024$9.00M$9.00M$9.00M1
2025$9.20M$9.20M$9.20M1
2026$9.30M$9.30M$9.30M1
2027$9.50M$9.50M$9.50M1

Earnings per share forecast

YearLowAverageHighAnalysts
2022$11.96$11.96$11.961
2023−$0.75−$0.75−$0.751
2024$0.15$0.15$0.151
2025$0.16$0.16$0.161
2026$0.17$0.17$0.171
2027$0.19$0.19$0.191

TherapeuticsMD, Inc. (TXMD) forecast — frequently asked questions

What are analysts forecasting for TherapeuticsMD, Inc.'s earnings?

The average analyst estimate for TherapeuticsMD, Inc. (TXMD) earnings per share in 2027 is 0.19, with individual estimates between 0.19 and 0.19.

How much revenue is TherapeuticsMD, Inc. expected to make?

Analysts forecast TherapeuticsMD, Inc. (TXMD) revenue of $9.50M in 2027, based on 1 published estimates.

How many analysts cover TXMD?

1 analyst contribute estimates for TherapeuticsMD, Inc. (TXMD). Thin coverage makes an average less reliable.

Analyst forecasts for other Drug Manufacturers - Specialty & Generic stocks

TEVA forecastZTS forecastVTRS forecastELAN forecastRDY forecastALKS forecastAMRX forecastLNTH forecastSUPN forecastBHC forecastAll Drug Manufacturers - Specialty & Generic stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.